Observations Regarding the 24-Month Results of the LIGHTSITE III Trial
- 1 May 2026
- journal article
- editorial
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (5) , 768-771
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
Funding Information
- Joseph J. & Marguerite DiSepio Retina Research Fund
- The Eng Family Fund for Excellence in Ophthalmology
This publication has 27 references indexed in Scilit:
- Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual AcuityJAMA Ophthalmology, 2020
- Geographic Atrophy and Foveal-Sparing Changes Related to Visual Acuity in Patients With Dry Age-Related Macular Degeneration Over TimeAmerican Journal of Ophthalmology, 2017
- Challenges in Applying the Results of Clinical Trials to Clinical PracticeJAMA Ophthalmology, 2016
- Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend ProtocolOphthalmology, 2015
- Natural History of Drusen Morphology in Age-Related Macular Degeneration Using Spectral Domain Optical Coherence TomographyOphthalmology, 2011
- Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention TrialOphthalmology, 2008
- A Simplified Severity Scale for Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2005
- 780 nm low power diode laser irradiation stimulates proliferation of keratinocyte cultures: Involvement of reactive oxygen speciesLasers in Surgery and Medicine, 1998
- Five-Year Incidence and Disappearance of Drusen and Retinal Pigment Epithelial AbnormalitiesArchives of Ophthalmology (1950), 1995
- Measurement of health statusControlled Clinical Trials, 1989